<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02343562</url>
  </required_header>
  <id_info>
    <org_study_id>CAIUNIPEDSURG-CR1</org_study_id>
    <secondary_id>PACTR201408000867421</secondary_id>
    <nct_id>NCT02343562</nct_id>
  </id_info>
  <brief_title>Probiotics for Prophylaxis of Postoperative Hirschsprungs Associated Enterocolitis</brief_title>
  <official_title>Probiotics for Prophylaxis of Postoperative Hirschsprungs Associated Enterocolitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hirschsprungs Associated Enterocolitis (HAEC) with incidence up to 30% postoperatively. The
      objective of the trial is to prevent postoperative HAEC by using Probiotics.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomised Controlled Study with two arms. All cases following up for post operative
      Hirschsprungs surgery are included in this study. First arm will receive a probiotics in the
      form of sachet for 6 months. Second arm will receive a multivitamin as placebo. Comparative
      analysis between the two groups for baseline and followup prevalence of Hirschsprungs
      associated enterocolitis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Probiotic Sachets</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>Probiotic Sachets</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Prevention of Hirschsprung's associated enterocolitis (HAEC)</measure>
    <time_frame>6 months</time_frame>
    <description>Absence of HAEC symptoms and signs; absence of fever, abdominal distension, loose stools (diarrhea) , bloody stools during the postoperative period for 6 months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement of stooling pattern of postoperative Hirschsprung's cases</measure>
    <time_frame>6 months</time_frame>
    <description>Bowel habits and motion data are recorded at base line (start of the study) and measured throughout the study. Number of motions per day, stool consistency and periodic culture and sensitivity analysis of the stools. Improvement is measured by optimising stool output to 2-3 times daily, stool consistency according to age should be semi-solid to solids. Stool analysis improvement criteria include better consistency, absence of pus cells or red blood cells and no growth on culture for pathogenic bacteria.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Hirschsprung Disease</condition>
  <arm_group>
    <arm_group_label>Probiotics Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Will receive Sachet-form probiotics</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Will receive off-the-shelf oral multivitamin</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotics</intervention_name>
    <description>Probiotics in the form of sachet will be given twice daily for a period of at least 6 months during the trial period.</description>
    <arm_group_label>Probiotics Group</arm_group_label>
    <other_name>Lacteol Forte</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Multivitamin off-the-counter.</description>
    <arm_group_label>Placebo Group</arm_group_label>
    <other_name>Multisanostol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hirschsprungs disease confirmed preoperative and postoperative specimen pathology

        Exclusion Criteria:

          -  Other cases of Enterocolitis and constipation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmoud MA Elfiky, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mahmoud MA Elfiky, M.D.</last_name>
    <phone>+201001557755</phone>
    <email>mfiky@kasralainy.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mostafa A Gad</last_name>
    <phone>+201002265009</phone>
    <email>mostafagad@kasralainy.edu.eg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cairo University Pediatric Hospital</name>
      <address>
        <city>Cairo</city>
        <zip>11432</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mahmoud Elfiky, MD</last_name>
      <email>mfiky@kasralainy.edu.eg</email>
    </contact>
    <contact_backup>
      <last_name>Mostafa Gad, MD</last_name>
      <email>mostafagad@kasralainy.edu.eg</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>El-Sawaf M, Siddiqui S, Mahmoud M, Drongowski R, Teitelbaum DH. Probiotic prophylaxis after pullthrough for Hirschsprung disease to reduce incidence of enterocolitis: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. J Pediatr Surg. 2013 Jan;48(1):111-7. doi: 10.1016/j.jpedsurg.2012.10.028.</citation>
    <PMID>23331802</PMID>
  </reference>
  <reference>
    <citation>Demehri, Farokh R., et al.</citation>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 9, 2015</study_first_submitted>
  <study_first_submitted_qc>January 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 22, 2015</study_first_posted>
  <last_update_submitted>January 27, 2018</last_update_submitted>
  <last_update_submitted_qc>January 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Mahmoud Elfiky, MD</investigator_full_name>
    <investigator_title>Lecturer of Pediatric Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enterocolitis</mesh_term>
    <mesh_term>Hirschsprung Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

